Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-139904
Filing Date
2016-09-02
Accepted
2016-09-02 20:37:49
Documents
1
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7806
  Complete submission text file 0001209191-16-139904.txt   9163
Mailing Address 60 WEST 66TH STREET, 26A NEW YORK NY 10023
Business Address
Bishop Hans Edgar (Reporting) CIK: 0001480212 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 161869679

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)